During the past decade, Sir Bobby Robson Cancer Trials Research Centre conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sir Bobby Robson Cancer Trials Research Centre" #1 sponsor was "Clovis Oncology, Inc." with 3 trials, followed by "Basilea Pharmaceutica" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Celgene" with 1 trials sponsored and "Heidelberg Pharma AG" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sir Bobby Robson Cancer Trials Research Centre" #1 collaborator was "Foundation Medicine" with 2 trials as a collaborator and "Myriad Genetics, Inc." with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Sir Bobby Robson Cancer Trials Research Centre" are "Fallopian Tube Cancer" (2 trials), "Ovarian Cancer" (2 trials), "Peritoneal Cancer" (2 trials), "Advanced Solid Tumors" (1 trials) and "Advanced Solid Tumours" (1 trials). Many other conditions were trialed in "Sir Bobby Robson Cancer Trials Research Centre" in a lesser frequency.

Most popular intervention types in "Sir Bobby Robson Cancer Trials Research Centre" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Amrubicin" (1 trials), "Avelumab 1200 mg in combination with gemcitabine/cisplatin" (1 trials), "Avelumab 1200 mg in combination with pemetrexed/carboplatin" (1 trials), "Avelumab 800 mg in combination with gemcitabine / cisplatin." (1 trials) and "Avelumab 800 mg in combination with pemetrexed / carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sir Bobby Robson Cancer Trials Research Centre" are 8 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Sir Bobby Robson Cancer Trials Research Centre". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Sir Bobby Robson Cancer Trials Research Centre, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sir Bobby Robson Cancer Trials Research Centre, 5 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".